Legislation signed by Gov. Phil Scott eliminates out-of-pocket expenses for diagnostic and supplemental imaging, which is crucial in ruling out breast cancer and a standard form of imaging for people at high-risk of breast cancer and survivors.
Susan G. Komen commends passage of HB 115 in Kentucky, which removes out-of-pocket costs for diagnostic and supplemental imaging. This is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer.
Susan G. Komen®, commends Representative Chantelle Nickson-Clark (D-Florissant) for working with Komen to expand eligibility for the MO HealthNet Breast and Cervical Cancer Treatment (BCCT) program, providing increased access to vital breast and cervical cancer treatment services.
Susan G. Komen is urging the U.S. House and Senate to bring the SCREENS for Cancer Act to a floor vote as soon as possible so breast health services are available to those who need them now.
Legislation introduced in Illinois would eliminate financial barriers to clinically appropriate genetic testing and additional screenings in an effort to detect breast cancers related to a known inherited gene mutation.
Legislation introduced in South Dakota will eliminate financial barriers to earlier breast cancer detection by eliminating out-of-pocket costs for diagnostic and supplemental breast imaging.
Legislation introduced in South Dakota will eliminate financial barriers to earlier breast cancer detection by eliminating out-of-pocket costs for diagnostic and supplemental breast imaging. This imaging is critical in ruling out or confirming breast cancer but can cost hundreds-to-thousands of dollars.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Lisa Subeck (D-Madison) and Senator Dianne Hesslebein (D-Middleton) for introducing legislation that would prohibit the use of step therapy protocols for metastatic cancer patients.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Ron Muzzall (R-Oak Harbor) and Representative Paul Harris (R-Vancouver) for introducing legislation that would prohibit the use of step therapy protocols for metastatic cancer patients.
Susan G. Komen®, the world’s leading breast cancer organization, will recognize innovative and successful physicians and scientists for their efforts in the advancement of the field of breast cancer at the 2023 San Antonio Breast Cancer Research Symposium, December 5-9, 2023.
Susan G. Komen® will hold a Metastatic Breast Cancer Impact Series Conference in Philadelphia that will include sessions with leading experts, survivor stories, wellness guidance, and interactive Q&A, offering attendees valuable insights, inspiration, practical tips, and community support.
Lower income breast cancer patients often struggle to afford life’s necessities such as housing, transportation and utilities due to direct and incidental costs related to their treatment, according to a new analysis by Susan G. Komen®.
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Dallas on Saturday, Oct. 21, 2023. The events will raise critical funds that support breast cancer patients, advance research and provide patient navigation services to better serve those impacted by the disease.
Susan G. Komen®, the world’s leading breast cancer organization, today announced a MORE THAN PINK Walk in Oklahoma City will be held on Saturday, Oct. 21, 2023. The events will raise critical funds that support breast cancer patients, advance research and provide patient navigation services to better serve those impacted by the disease.
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Arkansas this fall. The Northwest Arkansas MORE THAN PINK Walk will take place on Saturday, Oct. 7, 2023.
A new diagnostic scoring system, developed by renowned breast cancer experts, is now available as an easy-to-use online tool through Susan G. Komen®, the world’s leading breast cancer organization. This tool will help health care providers recognize and effectively diagnose a rare and aggressive breast cancer, inflammatory breast cancer.
Susan G. Komen®, the world’s leading breast cancer organization, will be hosting the annual 2023 Inland Empire MORE THAN PINK Walk on Sunday, October 8, 2023. The annual Walk will be held again at Town Square Park in Murrieta.
Susan G. Komen®, the world’s leading breast cancer organization, will be hosting the return of the 2023 Bay Area MORE THAN PINK Walk on Sunday, October 1, 2023, at the San Francisco Zoo & Gardens.
Susan G. Komen®, the world’s leading breast cancer organization, will be hosting the annual 2023 Seattle MORE THAN PINK Walk on Saturday, September 23. The annual Walk will be held for the first time at Woodland Park Zoo.
Susan G. Komen®, the world’s leading breast cancer organization, will be hosting the return of the 2023 Oregon and Southwest Washington MORE THAN PINK Walk on Saturday, September 16. The annual Walk will be held for the first time at the Oregon Zoo.
Susan G. Komen®, the world’s leading breast cancer organization, today announced the renaming of a metastatic breast cancer (MBC) grant to honor Rhonda Crocker Howell, a Raleigh resident, community leader and dedicated breast cancer advocate. The grant will be renamed The Susan G. Komen Metastatic Breast Cancer Collaborative Research Grant in honor of Rhonda Crocker Howell.
Susan G. Komen®, the world’s leading breast cancer organization, announced the fourth MBC-focused research grant supported through the Komen Metastatic Breast Cancer Collaborative Research Initiative (MBCCRI), a collaboration between Komen, Duke Cancer Institute and the University of North Carolina Lineberger Comprehensive Cancer Center, which pairs researchers from each of the organizations to work together and address significant gaps in our knowledge about MBC to advance patient care and improve patient outcomes.
Susan G. Komen commends commends the introduction of the Access to Breast Cancer Diagnosis (ABCD) Act of 2023 in the U.S. House of Representatives and the U.S. Senate. The legislation would remove a significant financial barrier to people receiving medically necessary diagnostic and supplemental breast imaging.
Susan G. Komen®, the world’s leading breast cancer organization has launched an innovative, cloud-based, research platform specifically for breast cancer patients and survivors to share their personal health data with Komen, where it will be used to accelerate breast cancer research and help discover the cures for breast cancer.
Susan G. Komen® filed an amicus brief supporting the U.S. Department of Justice’s request that the Fifth Circuit Court of Appeals issue a stay in Braidwood v. Becerra.
Susan G. Komen®, the world’s leading breast cancer organization, today announced the awarding of 49 new grants to researchers at 28 leading institutions in the U.S. The $19.3 million in new grants support Komen’s mission to end breast cancer through funding two focus areas: advancing precision medicine and eliminating disparities in breast cancer outcomes, while continuing Komen’s commitment to supporting the next generation of diverse leaders in breast cancer research.
Susan G. Komen is relieved to see the recommendation that all women get screened for breast cancer every other year starting at age 40. This is a meaningful step in the right direction but it is just a start.
Lawmakers in Nevada passed and Gov. Joe Lombardo signed legislation into law that removes out-of-pocket costs for diagnostic and supplemental imaging.
Susan G. Komen thanked lawmakers in Minnesota for passing and Gov. Tim Walz for signing legislation that eliminates out-of-pocket costs for diagnostic and supplemental breast imaging.
Susan G. Komen thanked Tennessee lawmakers and Governor Bill Lee for signing legislation into law that removes out-of-pocket costs for diagnostic and supplemental breast imaging.
Susan G. Komen thanked Washington lawmakers for passing, and Gov. Jay Inslee, for signing diagnostic and supplemental breast imaging legislation into law.
Susan G. Komen is pleased to see that the USPSTF has taken into account more recent scientific-based evidence and believes women of average risk should begin breast cancer screening at age 40. However, Komen believes screening should be done every year to catch cancer as early as possible when outcomes are generally better and treatment costs less.
Susan G. Komen commended the Maryland General Assembly for passing diagnostic and supplemental imaging and Governor Wes Moore for signing it into law. The bill removes a financial barrier to a critical form of screening for some high-risk individuals and an important step in determining the need for a biopsy to rule out or confirm breast cancer.
Susan G. Komen applauded Oklahoma lawmakers and Governor Kevin Stitt for implementing legislation to prohibit the use of step therapy requirements for metastatic cancer patients.
Legislation introduced in Maine would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 1,450 people will be diagnosed with breast cancer and more than 190 will die of the disease in Maine alone.
Susan G. Komen®, the world’s leading breast cancer organization, has appointed nine world-renowned medical and research experts to serve as advisors to the organization. These breast cancer experts will be part of a distinguished group, known as Komen Scholars, who help guide Komen’s research and scientific programs, with a focus on advancing discoveries to improve breast cancer outcomes for everyone.
Susan G. Komen® commends passage of diagnostic and supplemental imaging legislation in Montana. The bill was signed into law by Governor Greg Gianforte.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Donny Lambeth (R-Forsyth), Representative Mary Belk (D-Mecklenburg), Representative Donna McDowell White (R-Johnston) and Representative Becky Carney (D-Mecklenburg) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 10,730 people will be diagnosed with breast cancer and more than 1,450 will die of the disease in North Carolina alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Lisa Willner (D-Louisville) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 4,030 people will be diagnosed with breast cancer and more than 790 will die of the disease in Kentucky alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Kate Lieber (D-Beaverton) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 4,220 people will be diagnosed with breast cancer and more than 570 will die of the disease in Oregon alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Jodee Etchart (R-Billings) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 1,030 people will be diagnosed with breast cancer and more than 150 will die of the disease in Montana alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Dinah Sykes (D-Lenexa) and the House Committee on Health and Human Services for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Becky Massey (R-Knoxville) and Representative Rebecca Alexander (D-Jonesborough) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.
Legislation introduced in Arizona would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 6,240 people will be diagnosed with breast cancer and more than 920 will die of the disease in Arizona alone.
Susan G. Komen commends the introduction of legislation in California that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 32,020 people will be diagnosed with breast cancer and more than 4,680 will die of the disease in California alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Lori Berman (D-Boynton Beach) and Representative Marie Woodson (D-Hollywood) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 22,670 people will be diagnosed with breast cancer and more than 3,170 will die of the disease in Florida alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Pamela Beidle (D-Anne Arundel) and Delegate Sheree Sample-Hughes (D-Dorchester) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 5,760 people will be diagnosed with breast cancer and more than 850 will die of the disease in Maryland alone.
Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Nicole Miller (R-Edmond) for working with Komen to introduce legislation that would prohibit step therapy requirements for metastatic cancer patients. Komen believes patients and their physicians should be able to make treatment decisions based on the particular needs of each patient without the burden of harmful insurer policies.
Bipartisan legislation introduced in the U.S. House of Representatives would make financial benefits and health insurance immediately available to people with terminal breast cancer.
Legislation introduced in Mississippi would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy. In 2023, more than 2,610 people will be diagnosed with breast cancer and more than 470 will die of the disease in Mississippi alone.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right